Inflammatory response following central nervous system (CNS) injury contributes to progressive neuropathology and reduction in functional recovery. Axons are sensitive to mechanical injury and toxic inflammatory mediators, which may lead to demyelination. Although it is well documented that degenerated myelin triggers undesirable inflammatory responses in autoimmune diseases such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), there has been very little study of the direct inflammatory consequences of damaged myelin in spinal cord injury (SCI), i.e., there is no direct evidence to show that myelin debris from injured spinal cord can trigger undesirable inflammation in vitro and in vivo. Our data showed that myelin can initiate inflammatory responses in vivo, which is complement receptor 3 (CR3)-dependent via stimulating macrophages to express pro-inflammatory molecules and down-regulates expression of anti-inflammatory cytokines. Mechanism study revealed that myelin-increased cytokine expression is through activation of FAK/PI3K/Akt/NF-κB signaling pathways and CR3 contributes to myelin-induced PI3K/Akt/NF-κB activation and cytokine production. The myelin induced inflammatory response is myelin specific as sphingomyelin (the major lipid of myelin) and myelin basic protein (MBP, one of the major proteins of myelin) are not able to activate NF-κB signaling pathway. In conclusion, our results demonstrate a crucial role of myelin as an endogenous inflammatory stimulus that induces pro-inflammatory responses and suggest that blocking myelin-CR3 interaction and enhancing myelin debris clearance may be effective interventions for treating SCI.
Citation: Sun X, Wang X, Chen T, Li T, Cao K, Lu A, et al. (2010) Myelin Activates FAK/Akt/NF-κB Pathways and Provokes CR3-Dependent Inflammatory Response in Murine System. PLoS ONE5(2): e9380. https://doi.org/10.1371/journal.pone.0009380
Editor: Fabrizio Gelain, University of Milan-Bicocca, Italy
Received: October 29, 2009; Accepted: February 4, 2010; Published: February 23, 2010
Copyright: © 2010 Sun et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Science Foundation (DMS-0714589), National Institutes of Health (NIH) (R01-GM072611) and Joyce and Les Goodman scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Inflammatory response induced by trauma in the central nervous system (CNS), including traumatic brain injury (TBI) and spinal cord injury (SCI), contributes progressive neuropathology and reduction in functional recovery. The inflammatory response includes invasion of inflammatory cells, activation of CNS-resident glial cells and release of cytokines and chemokines , , . Pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6 and chemokines such as macrophage chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), and chemokine (C-X-C motif) ligand 10 (CXCL 10), are produced by both infiltrating cells and CNS-resident glial cells, orchestrating a pathogenic cascade leading to inflammation and axonal damage . TNF-α and IL-1 activate the nuclear factor kappa B (NF-κB) pathway and then further stimulate production of inflammatory mediators such as inducible nitric oxide synthase (iNOS) and prostaglandin E2 . IL-6 not only mediates spinal cord neural injury via JAK/STAT activation  but may also be a potential inhibitor of neurogenesis . In addition, these inflammatory processes enhance recruitment and activation of leukocytes, leading to amplification of inflammation and further tissue damage. However, there is no direct evidence to show where these pro-inflammatory cytokines come from and whether myelin is major stimulus responsible for inflammatory mediator production in SCI.
Myelin degeneration occurs after injury and in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Demyelinated areas in the CNS of patients with MS are characterized by inflammatory infiltrates that contain blood-derived myelin-specific T cells, B cells and macrophages. Degenerated myelin containing inhibitory molecules such as NogoA, Oligodendrocyte-myelin glycoprotein (OMgp) and myelin-associated glycoprotein (MAG) inhibits axon regeneration ,  and further activates complement system to destroy intact myelin. Although it is well documented that degenerated myelin triggers undesirable inflammatory responses in MS and EAE, there has been very little study of the direct inflammatory consequences of damaged myelin in spinal cord injury (SCI), i.e. there is no direct evidence to show that myelin debris from injured spinal cord can trigger undesirable inflammation in vitro and in vivo. Thus, study on understanding the mechanisms underlying inflammatory reaction induced by myelin is crucial to prevent further neuronal damage and develop the anti-inflammatory treatments of SCI.
Our present results demonstrate that myelin debris contributes to inflammatory responses in animal models via stimulating cytokine production. We further show that myelin-increased cytokines expression is via activation of NF-κB through FAK/PI3K/Akt signaling pathway and complement receptor 3 (CR3)-dependent. Inhibiting NF-κB activation abrogates myelin-induced cytokine production on macrophages. Our study provides the first direct evidence that myelin-CR3 interaction triggers undesirable inflammation in vitro and in vivo.
Reagents and Antibodies
All chemicals were purchased from Sigma (St. Louis, MO) unless otherwise indicated. The BAY 11-7082 was obtained from Biomol (Plymouth Meeting, PA). The antibodies against FAK, phospho-FAK (Tyr-576/577), p85, phospho-p85 (Tyr-458), Akt, phospho-Akt (Ser-473), IκB-α, phospho-IκB-α (Ser-32/36) and β-actin were purchased from Cell Signaling Technology (Danvers, MA). The rabbit-anti-p65 antibody, goat-anti-MIF antibody and rabbit-anti-MIF antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit-anti-IBA-1 antibody was from Wako USA (Richmond, VA). Rat-anti-Ly-6G (Gr-1) antibody was obtained from eBioscience (San Diego, CA). Alexa 546-conjugated goat-anti-rabbit IgG, FITC-conjugated rabbit-anti-rat IgG, HRP-conjugated goat-anti-rabbit IgG and HRP-conjugated rabbit-anti-mouse IgG antibodies were from Invitrogen (Carlsbad, CA).
Cells and Mice
Bone marrows were harvested from C57BL/6 wild type (WT) and CR3 knockout (KO) mice (CD11b deleted) (The Jackson Laboratory, Bar Harbor, Maine) and cultured in DMEM containing 10% FBS and 15% L929 cells-conditioned medium as a source of M-CSF. Bone marrow-derived macrophages were used after 7–10 days of culture. All mice were maintained in pathogen-free animal facility in Rutgers University. Animal protocols were approved by Animal Care and Facilities Committee in Rutgers University.
Myelin was isolated from the brains of 3-month-old mice by sucrose density gradient centrifugation (0.32 M and 0.85 M) at 75000×g, as described previously . The protein content of myelin was determined by Bradford method with bovine serum albumin as the standard. The endotoxin concentration of myelin debris was below the detection limit by Limulus Amebocyte Lysate assay. Myelin was used to stimulate cells with concentration of 100 µg myelin protein per milliliter in all experiments.
Myelin Stimulation in Peritoneal Cavity
C57BL/6 WT and CR3 KO mice were injected i.p. with myelin (25 mg/kg body weight) or PBS alone for control. Mice were sacrificed at different time points and peritoneal lavage was performed. Cells in peritoneal lavage fluid were counted and stained with Diff-Quick staining kit (IMEB Inc., San Marcos, CA). Remaining lavage fluids were centrifuged at 400×g for 10 minutes and the cytokines in supernatants were detected by ELISA.
Myelin Injection in Spinal Cord
Myelin in PBS was adjusted to 125 µg/kg body weight and a total volume of 0.5 µl was stereotaxically injected into the spinal cord at T8–T10 vertebrae by a T10 laminectomy using a microliter syringe (Hamilton Company, NV) fixed in a stereotaxi frame. Injection of PBS alone was used for control. Mice were sacrificed and perfused at 1, 4 and 7 days after injection, and spinal cords were fixed and frozen sectioned for immunostaining.
Immunofluorescent Staining and Quantitative Analysis
Cells were seeded in 24-well plate at 1×105 cells/well and incubated with culture medium containing myelin for different periods of time and then fixed in 4% paraformaldehyde (PFA) for 15 minutes at room temperature (RT). For the frozen section, spinal cord tissues were fixed in 4% PFA at 4°C overnight. After being washed with PBS for three times, cells or tissues were blocked in PBS with 1% BSA, 0.4% Triton X-100 for 20 minutes, then incubated with primary antibody for at 4°C overnight. After the incubation with secondary antibody for 1 hour, all images were acquired at RT using Zeiss Axiovert 200 M Microscope (Carl Zeiss, Germany) with 20×/0.4, equipped with AxioCam camera (Carl Zeiss, Germany) and software Axiovision 4.6 (Carl Zeiss, Germany). Injection regions and marginal regions were evaluated, six fields within each region were randomly selected. The numbers of Ly-6G and IBA1 positive cells were counted and divided by areas for each field (pixel×pixel). Numbers of cells per 100,000 pixel×pixel area were obtained as cell numbers per arbitrary unit for further analysis.
Cells were washed with PBS, and directly lysed in RIPA buffer containing phosphatase inhibitors and proteinase inhibitors. Protein samples were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins on the gel were transferred onto nitrocellulose membranes (GE Healthcare, UK) that were blocked with 5% milk in Tris-Buffered Saline containing 0.1% Tween 20 (TBST) for 1 hour at RT. Afterwards, the membranes were incubated with the indicated primary antibodies overnight at 4°C. After being washed with TBST, the membranes were incubated with the appropriate secondary antibodies. The immunoreactive bands were detected by using ECL Plus Western Blotting Detection System (GE Healthcare, UK) and analyzed by Kodak Molecular Imaging Software (v4.0.4) for intensities. Phosphorylation levels were shown by normalizing intensities of phosphorylated proteins to those of non-phosphorylated total proteins.
RNA Isolation and Quantitative Real-Time (qRT)-PCR
Cells were incubated with myelin for 6 and 12 hours with or without the pre-incubation of inhibitors. Total RNA was isolated by TRIZOL method under the instruction of user manual and reverse-transcribed into cDNA by using oligo-dT primers and SuperScript II reverse transcriptase (Invitrogen). The primers used were shown in Supporting Information Table S1. The ABI 7900HT detection system (Applied Biosystems, UK) was used for qRT-PCR. SYBR Green dye (Applied Biosystems, UK) was used to monitor the replication of PCR products. Quantities of products were obtained by standard curve and then normalized to GAPDH quantity. The gene expression level was represented by the ratio of gene/GAPDH.
Enzyme-Linked Immunosorbent Assay (ELISA)
The supernatants of cells incubated with myelin were collected for detection of mouse TNF-α, IL-1β and MIF. ELISA for mouse IL-1β and TNF-α were performed by Duoset ELISA Development kit from R&D Systems (Minneapolis, MN). ELISA for mouse MIF was done under the instruction of manual for human MIF ELISA kit from R&D Systems.
Data in figures are presented as mean ± SEM, with n representing the number of experiments. Statistical significance was evaluated using Student's unpaired t-tests or one-way analysis of variance (ANOVA) followed by Dunnett's post-test for multiple comparisons among groups. Statistical significance was set at P value <0.05.
Myelin Is a Direct Inflammatory Stimulus which Induces Inflammation in Animal Models
Although it is well documented that degenerated myelin triggers undesirable inflammatory responses in MS and EAE, there has been very little study to show that myelin debris from injured spinal cord can trigger undesirable inflammation directly in vitro and in vivo. We first assessed whether myelin is an inflammatory stimulus in vivo. We used mouse peritonitis model, a well-documented experimental animal model for studying pathogenesis of inflammatory stimuli and evaluating in vivo efficacy of anti-inflammatory and anti-infectious treatments. We administrated myelin (25 mg/kg body weight) or PBS (as control) intraperitoneally (i.p.) to C57BL/6 WT and CR3 KO mice, respectively and then performed peritoneal lavage and collected cells at 0, 4, 24 and 72 hours after the myelin injection. The number of cells in peritoneal lavage rapidly increased after myelin injection in WT mice (Figure 1A) and few neutrophils were found in mice injected with PBS alone. The total number of cells in WT mice at all time points was significantly higher than that of CR3 KO mice (Figure 1B). Furthermore, neutrophil infiltration dramatically increased in WT mice by 4 h after myelin injection and then declined quickly at 24 h after injection (Figure 1C). In comparison, neutrophil infiltration in CR3 KO mice was significantly reduced at all time points (Figure 1C). Macrophage infiltration started at 72 h after myelin injection in WT mice (Figure 1C) and the CR3 KO mice showed the less macrophage infiltration compared to WT mice (Figure 1C). In addition, increased levels of IL-1β and TNF-α in peritoneal lavage fluid were detected at time 4 h and declined after 24 h (Figure 1D) and significantly higher levels of IL-1β and TNF-α were detected in WT mice compared to CR3 KO mice (Figure 1D). By contrast, peritoneal injection of PBS did not induce significant cell infiltration and cytokine production in both WT and CR3 KO mice (Figure 1).
(A) Morphology of infiltrated cells in peritoneal cavity from WT mice. Neutrophils were indicated with black arrow and macrophages were indicated with white arrow. (Scale bar = 50 µm). (B) The total number of cells in peritoneal cavity. (C) Number of infiltrated neutrophils and macrophages in peritoneal cavity. (D) Levels of TNF-α and IL-1β in peritoneal lavage fluid detected by ELISA. Data were expressed as mean ± SEM. (n = 4 at each time point, *P<0.05 vs. WT + PBS; #P<0.05 vs. CR3 KO + Myelin; t-test).
We further assessed whether myelin is able to generate inflammatory response in mouse spinal cord. Myelin at total volume of 0.5 µL (125 µg/kg body weight) or PBS was stereotaxically injected into the spinal cord at T8–T10 vertebrae by a T10 laminectomy in WT and CR3 KO mice. Mice were sacrificed at 1, 4 and 7 days after myelin injection. Myelin injection induced large amount of leukocyte infiltration (Figure 2). We assessed the infiltration of macrophages and neutrophils by using IBA-1 (ionized calcium-binding adaptor molecule 1) and Ly-6G (lymphocyte antigen 6 complex, locus G, also known as Gr-1), respectively. The mouse Gr-1 antigen is a G-protein linked meyloid differentiation marker also known as Ly-6G . Double immunostaining showed that infiltrated neutrophils were Ly-6G positive but negative for IBA-1 (Figure 2A). Kinetics of these cells infiltrated into the spinal cord is much earlier than IBA-1 positive macrophages (Figure 2C, D, E and F). Injection of PBS did not induce significant neutrophil infiltration in either WT or CR3 KO mice (Figure 2B and D). In myelin injection region in the spinal cord from CR3 KO mice, neutrophil infiltration was significantly reduced by more than 50% relative to that in WT mice at all time points after myelin injection (Figure 2C and D). Similar pattern can be observed in the marginal region of myelin injection (Figure 2C and D). After 7 days of myelin injection, few neutrophils can be observed in CR3 KO mice, while neutrophils in the spinal cord from WT mice still can be detected (Figure 2D). In addition, macrophages were not detected within the injection region in either WT or CR3 KO mice at 1 day after myelin injection. The number of macrophages significantly increased by 4 days at injection and marginal region in WT mice (Figure 2E and F). Macrophage infiltration was significantly suppressed in CR3 KO mice at 4 days after myelin injection (Figure 2E and F). However, there were no significant differences for macrophage infiltration between WT and CR3 KO mice at 7 days post-injection (Figure 2F). By contrast, injection of PBS did not induce significant macrophage infiltration in either WT or CR3 KO mice (Figure 2B and F).
(A) Neutrophils were positive for Ly-6G (green) but negative for IBA-1 (red) detected by double immunostaining. (B) Neutrophil and macrophage infiltration in spinal cord at 1 d after PBS injection detected by double immunostaining. (C) Neutrophil infiltration (Ly-6G+, green) in spinal cord at 1 d after myelin injection, along with injection region (solid line), marginal region (dashed line) and enlarged injection region. (D) The number of neutrophils at injection region and marginal region in spinal cord at 1 d after myelin or PBS injection. (E) Macrophage infiltration (IBA-1+, red) in spinal cord at 4 d after myelin injection, along with injection region (solid line), marginal region (dashed line) and enlarged injection region. (F) The number of macrophages at injection and marginal region in spinal cord at 4 d after myelin or PBS injection. Scale bar = 200 µm. Data were expressed as mean ± SEM. (n = 4 at each time point, *P<0.05 vs. WT + PBS; #P<0.05 vs. CR3 KO + myelin; t-test).
Effect of Myelin on Pro-Inflammatory Cytokine Expression In Vitro
We then determined whether myelin treatment has effects on pro-inflammatory cytokine expression by inflammatory cells such as macrophages. We performed quantitative real-time (qRT)-PCR and ELISA on mouse bone marrow-derived macrophages to measure mRNA and protein levels of cytokines after myelin stimulation. As shown in Figure 3, mRNA levels of several of cytokines increased at 6 h and 12 h after myelin treatment. There was dramatic increase in expression of TNF-α, IL-1β, IL-6 and IL-12. Macrophage migration inhibitory factor (MIF) and matrix metalloproteinase 9 (MMP9) were also increased by myelin stimulation (Figure 3A). Interestingly, the expression of anti-inflammatory cytokines such as IL-4 and TGFβ1 was inhibited by myelin (Figure 3A). In addition to pro-inflammatory cytokines (e.g. TNF-α and IL-1β), expression of chemokines MIP-1α/CCL3 (chemokine (C-C motif) ligand 3) and CXCL10/IP-10 (interferon-inducible protein 10) significantly increased in macrophages stimulated by myelin (Figure 3A). However, myelin did not significantly enhance MCP-1/CCL2 production (Figure 3A). The protein levels of TNF-α, IL-1β and MIF secreted by macrophages treated with myelin were confirmed by ELISA (Figure 3B). Myelin exerts a time-dependent effect on expression of TNF-α, IL-1β and MIF.
(A) Cytokines and chemokines in the cells detected by qRT-PCR. (B) Cytokines in the supernatants of cell culture detected by ELISA. Data were expressed as mean ± SEM and similar results were obtained from three independent experiments. (n = 3. *P<0.05 vs. control; one way ANOVA with Dunnett's post-test).
Myelin Induces NF-κB Activation
We investigated signaling pathways triggered by myelin in macrophages. NF-κB is a key participant centrally in the inflammatory response to lipopolysaccharide (LPS) and other pro-inflammatory stimuli. We therefore examined the effects of NF-κB modulation on myelin-induced stimulation of macrophages. Myelin treatment increased the level of phosphorylated IκB-α, an inhibitory subunit of NF-κB, from 5 minutes up to 30 minutes (Figure 4A). Meanwhile, there was degradation of total IκB-α after myelin treatment (Figure 4A). Phosphorylation of IκB-α is considered to induce its degradation, which then releases NF-κB and confers it transcriptional activity. Pre-incubation with NF-κB inhibitor BAY 11-7082 (10 µM) for 30 minutes blocked IκB-α activation induced by myelin (Figure 4B). We also did immunofluorescence to detect subcellular distribution of p65, a major component of NF-κB. As shown in Figure 4C, p65 (stained as red) was located in the cytoplasm in the absence of myelin. After 90 minutes of exposure to myelin, p65 moved into the nuclei and this translocation can be abolished by pre-incubation of BAY 11-7082 (Figure 4C). The data indicate that myelin rapidly activates NF-κB in macrophages. By contrast, sphingomyelin (25 µg/mL), the major lipid component of myelin and MBP (1 µg/mL) are not able to activate NF-κB pathways (Figure 4D and E).
(A) Bone marrow-derived macrophages were incubated with myelin for indicated time and phosphorylation/degradation of IκB-α were assessed by western blot. (B) Effect of NF-κB inhibitor BAY 11-7082 on myelin-induced IκB-α phosphorylation and degradation. (C) Myelin-induced p65 translocation in macrophages detected by immunofluorescent staining. p65 was stained red and nuclei were stained with DAPI (blue) (Scale bar = 10 µm). (D) Sphingomyelin (25 µg/mL) had no effect on IκB-α phosphorylation and degradation macrophages. (E) MBP (1 µg/mL) had no effect on IκB-α phosphorylation and degradation in bone marrow-derived macrophages. The inhibitor was used for 30-minute pre-incubation before myelin incubation. Phosphorylation levels were normalized to non-phosphorylated total proteins. Similar results were obtained from three independent experiments.
Inhibition of NF-κB Activity Suppresses Myelin-Induced Cytokine Expression
We further investigated whether inhibition of NF-κB activity could suppress the myelin-induced cytokine expression. Macrophages were pre-incubated with BAY 11-7082 for 30 minutes and then incubated with myelin for 12 or 24 hours. BAY 11-7082 significantly inhibited myelin-induced expression of TNF-α, IL-1β, IL-6, IL-12, MIF and CXCL10 at mRNA level (Figure 5A) detected by qRT-PCR and the protein level by ELISA (Figure 5B). These data indicate that myelin is a strong pro-inflammatory stimulus which can enhance the expression of a variety of pro-inflammatory cytokines and chemokines in macrophages by activation of NF-κB. Inhibition of NF-κB activation abrogates the stimulatory effects of myelin on cytokines production by macrophages.
(A) Macrophages were pre-treated with BAY 11-7082 for 30 minutes and then treated with myelin for 12 hours. Cytokines at transcriptional level were detected by qRT-PCR. (B) Macrophages were pre-treated with BAY 11-7082 for 30 minutes and then treated with myelin for 24 hours. Cytokines at protein level were detected by ELISA. Data were expressed as mean ± SEM and similar results were obtained from three independent experiments. (n = 3, *P<0.05 vs. control; #P<0.05 vs. BAY treatment; t-test).
Myelin-Induced NF-κB Activation and Cytokine Expression Is CR3-Dependent
Binding and phagocytosis of myelin by macrophages is mediated by complement receptor 3 (CR3, CD11b/CD18), a member of integrin family , . CR3 interacts with many molecules in the extracellular matrix (ECM), such as iC3b and pathogens. Binding of ECM (e.g. fibrinogen, collagen, ICAM-1, and ICAM-2) with integrin, including CR3/MAC-1, can induce integrin activation and then regulate a variety of cell functions, including proliferation, apoptosis, migration and survival. We therefore ascertained whether myelin-induced NF-κB activation and cytokine expression were CR3-dependent. Myelin cannot phosphorylate and degrade IκB-α in bone marrow-derived macrophages from CR3 KO mice (Figure 6A). Furthermore, macrophages from CR3 KO mice did not respond to myelin by increasing mRNA (Figure 6B) and protein expression (Figure 6C) of cytokines.
(A) Macrophages from CR3 KO mice were treated with myelin for the indicated time and phosphorylation/degradation of IκB-α were assessed by western blot. (B) Macrophages from CR3 KO mice were treated with myelin for 6 and 12 hours. Cytokine and chemokine expression in cells at mRNA levels were detected by qRT-PCR. (C) Macrophages from WT and CR3 KO mice were treated with myelin for 24 hours and cytokines in the supernatants of cell culture were detected by ELISA. Phosphorylation levels were normalized to non-phosphorylated total proteins. Data were expressed as mean ± SEM and similar results were obtained from three independent experiments. (n = 3, *P<0.05 vs. CR3 KO + myelin; t-test).
Myelin Induces FAK Phosphorylation
Next we studied to reveal the upstream molecules involved in myelin-induced NF-κB activation. Myelin interacts with CD11b subunit of CR3 and the ligand-CR3 interaction regulates a variety of biological functions through activation of its downstream effector, focal adhesion kinase (FAK) , . FAK is a protein tyrosine kinase that is important in serving integrin signaling pathways . Activated FAK interacts with Src family kinases or PI3K to initiate downstream signaling pathways . We therefore determined whether NF-κB activation by myelin is via FAK activation. Figure 7 shows that FAK underwent transient FAKTyr-576/577 phosphorylation at 5 minutes after myelin treatment in macrophages. The phosphorylation of FAK (pFAK) by myelin was also CR3-dependent as myelin failed to phosphorylate FAK in macrophages from CR3 KO mice (Figure 7). These results suggest that myelin induces rapid FAK phosphorylation in CR3-dependent manner.
Bone marrow-derived macrophages from WT and CR3 KO mice were treated with myelin for the indicated time and phosphorylation of FAK (pFAK) was assessed by western blot. Phosphorylation levels were normalized to non-phosphorylated total proteins. Similar results were obtained from three independent experiments.
PI3K/Akt Serves as Upstream Kinases for NF-κB Activation by Myelin
FAK can activate CrK/CAS, PI3K and Grb2/Ras cell signaling pathways to regulate cell proliferation, motility, differentiation and intracellular trafficking . As NF-κB can be activated through many different pathways, including phosphatidylinositol 3-kinase (PI3K) and its major downstream kinase, Akt , we hypothesize that PI3K/Akt contributes to myelin-induced NF-κB activation. Figure 8A shows myelin treatment phosphorylated p85 regulatory subunit of PI3K and Akt in macrophages from WT mice but not in macrophages from CR3 KO mice. Pre-incubation with PI3K inhibitor, LY-294002 (50 µM) not only effectively inhibited myelin-induced phosphorylation of p85 in macrophages but also inhibited phosphorylation of IκB-α and its degradation induced by myelin (Figure 8B). The Akt inhibitor IV (1 µM), but not protein kinase C (PKC) inhibitor Gö 6983 (5 µM) inhibited IκB-α phosphorylation and degradation in macrophages (Figure 8C). Moreover, phosphorylation of Akt in macrophages can be abolished by both Akt inhibitor IV and PI3K inhibitor LY-294002, but not by PKC inhibitor Gö 6983 and NF-κB inhibitor BAY 11-7082 (Figure 8D), suggesting that Akt is specifically activated by PI3K and Akt is the upsteam molecule of NF-κB. Accordingly, PI3K activating NF-κB was confirmed by immunofluorescent staining of p65 as the inhibitor of PI3K (LY-294002) suppressed p65 translocation from cytoplasm to the nuclei (Figure 8E, I, II and III). Moreover, the Akt inhibitor IV and NF-κB inhibitor BAY 11-7082 readily blocked nuclei translocation of p65 by myelin administration (Figure 8E, IV and V). In contrast, Gö 6983 had no inhibitory effect on p65 nuclei translocation (Figure 8E, VI). These results suggest that PI3K/Akt is upstream kinases for NF-κB signaling and myelin activates the PI3K/Akt/NF-κB signaling pathway. We also showed that inhibitors of PI3K and Akt blocked the myelin induced cytokine production (Figure 9).
(A) Phosphorylation of p85 and Akt in bone marrow-derived macrophages from WT and CR3 KO mice treated with myelin for the indicated time. (B) Effect of PI3K inhibitor LY-294002 on myelin-induced IκB-α phosphorylation and degradation in macrophages. (C) Effect of Akt inhibitor IV on myelin-induced IκB-α phosphorylation and degradation in macrophages. (D) Effect of inhibitors of PI3K, Akt, NF-κB and PKC on myelin-induced Akt phosphorylation in macrophages. (E) Macrophages were pretreated with inhibitors of PI3K, Akt, NF-κB and PKC for 30 minutes, respectively and then incubated with myelin for 90 minutes. Myelin-induced p65 translocation in macrophages was detected by immunofluorescent staining. p65 was stained red and nuclei were stained with DAPI (blue) (Scale bar = 10 µm). All inhibitors were used for 30-minute pre-incubation before myelin incubation. Phosphorylation levels were normalized to non-phosphorylated total proteins. Similar results were obtained from three independent experiments.
Macrophages were pre-treated with LY-294002 (A) or Akt inhibitor IV (B) for 30 minutes and then treated with myelin for 12 hours. Cytokines at transcriptional level were detected by qRT-PCR. Data were expressed as mean ± SEM and similar results were obtained from three independent experiments. (n = 3, *P<0.05 vs. control; #P<0.05 vs. inhibitor treatment; t-test).
Trauma and inflammation damage myelin, creating myelin debris. Myelin debris contains several inhibitors of axonal regeneration . Although the inhibitory effect on axonal regeneration has been well documented, little direct evidence is available concerning myelin-induced changes in inflammation in spinal cord injury. Our findings presented in this study indicated that myelin is a strong inflammatory stimulus that CR3-myelin interaction enhances expression of pro-inflammatory mediators, down-regulates the production of anti-inflammatory cytokines in macrophages, and triggers undesirable inflammation in vivo.
These data are crucial for our understanding of the role of myelin in CNS injury and inflammation. Myelin debris generated after CNS injury not only inhibits axonal regeneration and CNS remyelination  but also stimulates inflammatory responses. In our present study we showed that the myelin induced inflammatory response is myelin specific as sphingomyelin (the major lipid of myelin) and MBP (one of the major proteins of myelin) are not able to activate NF-κB signaling pathway. Other myelin specific lipids and proteins may have capacity to activate NF-κB. For example, sulfatide, one of major lipid component of myelin sheath, might be a target autoantigen in MS and EAE , . Recent in vitro results suggested that sulfatide can activate inflammatory response in microglia cells via activation of MAKPs and NF-κB . It is not clear whether CR3 or other receptors is involved in sulfatide-induced NF-κB activation. Further study is needed to investigate whether NF-κB in macrophages can be activated by other myelin specific lipids and proteins.
Myelin not only up-regulates expression of pro-inflammatory mediators such as TNF-α, IL-1β, IL-6, IL-12, MIP-1α and CXCL10 but also down-regulates production of anti-inflammatory cytokines such as IL-4 and TGF-β1. These cytokines play important roles in pathology of CNS injury and inflammation. For example, TNF-α and IL-1β are well-documented pathogenic mediators involved in CNS inflammation and axonal degeneration. Overexpression of IL-6 and IL-12 induced neurodegenerative and inflammatory pathology, respectively . IL-6 and IL-12 deficient mice fail to respond to experimental autoimmune encephalomyelitis (EAE) , . IL-4, a well-known anti-inflammatory cytokine, has marked inhibitory effects on the expression and release of the pro-inflammatory cytokines , . TGF-β1 exerts potent anti-inflammatory and neuroprotective properties on a LPS-induced model of CNS inflammation and degeneration . CXCL10 and its receptor CXCR3 play a critical role in multiple sclerosis, particularly in leukocyte recruitment into the CNS , . Taken together, myelin up-regulation of pro-inflammatory mediators in CNS injury and down-regulation of anti-inflammatory cytokines combine to amply the inflammatory responses.
Kerschensteiner et al observed that axonal degeneration and myelin breakdown can happen as early as 30 minutes after injury . In combination with our results, such early myelin debris provides rapid and strong stimuli that stimulate macrophages to produce cytokines including TNF-α and IL-1β and therefore the early increased cytokine expression can be observed after spinal cord injury by Pan et al  who showed that cytokines mRNA such as TNF-α, IL-6 and IL-1β were increased during the first 2 hours following spinal cord injury, prior to the appearance of circulating cells. Myelin debris is cleared rapidly and efficiently in peripheral nervous system (PNS) , . However, myelin debris can persist for years after degeneration of CNS axons as myelin debris can not be efficiently cleared in CNS . Therefore, myelin debris not only provides an early the inflammatory environment for axons but also prolong inflammation, thereby amplifying secondary injury and inhibiting axonal regeneration. Therefore, clearance of myelin debris in CNS may be critical for allowing regeneration.
Myelin can induce macrophages to produce pro-inflammatory cytokines and NO in vitro by van der Laan et al . However, there were lack of in vivo data and cellular mechanism study about how myelin stimulates cytokine production. Understanding the molecular underlying myelin stimulation of inflammatory response should prove vital insights into indentifying new therapies that reduce the secondary damage and enhance regeneration. Our results indicate that myelin strongly activates FAK/PI3K/Akt/NF-κB pathway in macrophages and increases the expression of inflammatory mediators in WT mice but not in CR3 KO mice, suggesting that NF-κB activation by myelin may be CR3-dependent (schematized in Figure 10). Myelin-induced cytokine production is more likely a direct effect as NF-κB can be activated within 5 min, suggesting myelin interacts with macrophages directly rather than the consequence of myelin phagocytosis by macrophages or cytokines released in response to myelin binding to CR3 working in an autocrine manner to trigger NF-κB. Treatment with inhibitors of PI3K, Akt and NF-κB or deletion of CR3 reversed myelin-induced NF-κB activation and also inhibited myelin–mediated production of pro-inflammatory mediators. Therefore, myelin induces cytokine production by activating FAK/PI3K/Akt/NF-κB through CR3-dependent mechanisms. Further studies are needed to identify or rule out other signaling pathways contributing to the myelin-induced cytokine expression.
Myelin debris generated in injured CNS or demyelinating diseases may bind to CR3 and then activate NF-κB through FAK/PI3K/Akt pathway, therefore initiating gene expression of pro-inflammatory mediators.
This study suggests a few strategies to reduce inflammatory response and secondary damage and to promote neuronal regeneration: 1) enhance clearance of myelin debris such as increasing phagocytotic uptake of myelin; 2) inactivation of PI3K/Akt/NF-κB pathway; and 3) targeting CR3-myelin interaction. Although inhibition of NF-κB activity has been shown to reduce inflammation and improves function recovery after SCI , enhancement of myelin debris clearance and targeting CR3-myelin interaction after SCI should be further investigated. Leukemia inhibitory factor (LIF) not only acts as a neurotrophic factor  in CNS but also inhibits the production of oxygen radicals and TNF-α, and stimulates myelin uptake by macrophages , suggesting that LIF may be useful for treating CNS trauma or other demyelinating diseases. In addition, phagocytosis can be also regulated by transmembrane molecules. For example, CD200-CD200R interaction inhibits macrophage/microglia function , . Blocking CD200-CD200R interaction and stimulation of macrophage/microglia activation may enhance clearance of CNS myelin debris . Given the crucial roles of CR3 in inflammation and the finding that myelin can initiate inflammatory responses in CR3-dependent manner, blocking CR3-myelin interaction may be beneficial for treatment of CNS injury. It has been shown that myelin clearance is mediated primarily by CR3, however, our in vitro and in vivo data showed that microglia cells expressing high level of CR3 have poorer efficiency for myelin clearance and myelin clearance by macrophages from CR3 KO mice was not impaired (see Supporting Information Figure S1 and S2), which consistent with the studies from other group showing myelin is not phagocytosed by microglia after SCI  and myelin phagocytosis by macrophages may be via galectin-3/Mac-2 . These studies suggested that targeting CR3 may be possible to suppress myelin-induced inflammation without affecting myelin clearance.
Primer sequences for qRT-PCR
(0.04 MB DOC)
Myelin clearance by macrophages from WT and CR3 KO mice. (A) Bone marrow-derived macrophages from WT and CR3 KO mice were incubated with myelin for 48 hours and cells were stained with Oil Red O and MBP antibody, respectively. (B) In vivo study showed that myelin debris can be phagocytosed by macrophage from WT and CR3 KO mice after spinal cord injury. Representative micrographs of myelin uptake by macrophage in the injured spinal cord at 2 weeks after injury in WT and CR3 KO mice using confocal microscopy. Macrophage was labeled with IBA-1 (green) and myelin debris was stained by Oil Red O (red). Scale bar = 10 µm.
(3.94 MB TIF)
Comparison of myelin uptake by bone marrow-derived macrophages and primary microglia cells. Bone marrow-derived macrophages and primary microglia cells were incubated with myelin for 3 hours. Non-ingested myelin was washed away with PBS and cells were lysed. Intracellular MBP was assessed by ELISA. Data were expressed as mean ± SEM. (n = 3, *P<0.05 vs. control; #P<0.05 vs. microglia cells + Myelin; t-test).
(0.00 MB TIF)
Conceived and designed the experiments: YR. Performed the experiments: XS XW TC TL KC AL YC DS. Analyzed the data: XS. Wrote the paper: XS YR. Funding the personnel: JL JF WY.
- 1. Donnelly DJ, Popovich PG (2008) Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209: 378–388.DJ DonnellyPG Popovich2008Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.Exp Neurol209378388
- 2. Hausmann ON (2003) Post-traumatic inflammation following spinal cord injury. Spinal Cord 41: 369–378.ON Hausmann2003Post-traumatic inflammation following spinal cord injury.Spinal Cord41369378
- 3. Popovich PG, Wei P, Stokes BT (1997) Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377: 443–464.PG PopovichP. WeiBT Stokes1997Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats.J Comp Neurol377443464
- 4. Pineau I, Lacroix S (2007) Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500: 267–285.I. PineauS. Lacroix2007Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved.J Comp Neurol500267285
- 5. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, et al. (2004) Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 15: 415–436.C. ProfyrisSS CheemaD. ZangMF AzariK. Boyle2004Degenerative and regenerative mechanisms governing spinal cord injury.Neurobiol Dis15415436
- 6. Kaplin AI, Deshpande DM, Scott E, Krishnan C, Carmen JS, et al. (2005) IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 115: 2731–2741.AI KaplinDM DeshpandeE. ScottC. KrishnanJS Carmen2005IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.J Clin Invest11527312741
- 7. Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302: 1760–1765.ML MonjeH. TodaTD Palmer2003Inflammatory blockade restores adult hippocampal neurogenesis.Science30217601765
- 8. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, et al. (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403: 434–439.MS ChenAB HuberME van der HaarM. FrankL. Schnell2000Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.Nature403434439
- 9. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, et al. (1994) Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13: 805–811.L. McKerracherS. DavidDL JacksonV. KottisRJ Dunn1994Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth.Neuron13805811
- 10. Norton WT, Poduslo SE (1973) Myelination in rat brain: method of myelin isolation. J Neurochem 21: 749–757.WT NortonSE Poduslo1973Myelination in rat brain: method of myelin isolation.J Neurochem21749757
- 11. Fleming TJ, Fleming ML, Malek TR (1993) Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 151: 2399–2408.TJ FlemingML FlemingTR Malek1993Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family.J Immunol15123992408
- 12. Rotshenker S (2003) Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease. J Mol Neurosci 21: 65–72.S. Rotshenker2003Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease.J Mol Neurosci216572
- 13. van der Laan LJ, Ruuls SR, Weber KS, Lodder IJ, Dopp EA, et al. (1996) Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J Neuroimmunol 70: 145–152.LJ van der LaanSR RuulsKS WeberIJ LodderEA Dopp1996Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide.J Neuroimmunol70145152
- 14. Zhang H, Colman RW, Sheng N (2003) Regulation of CD11b/CD18 (Mac-1) adhesion to fibrinogen by urokinase receptor (uPAR). Inflamm Res 52: 86–93.H. ZhangRW ColmanN. Sheng2003Regulation of CD11b/CD18 (Mac-1) adhesion to fibrinogen by urokinase receptor (uPAR).Inflamm Res528693
- 15. Rubel C, Gomez S, Fernandez GC, Isturiz MA, Caamano J, et al. (2003) Fibrinogen-CD11b/CD18 interaction activates the NF-kappa B pathway and delays apoptosis in human neutrophils. Eur J Immunol 33: 1429–1438.C. RubelS. GomezGC FernandezMA IsturizJ. Caamano2003Fibrinogen-CD11b/CD18 interaction activates the NF-kappa B pathway and delays apoptosis in human neutrophils.Eur J Immunol3314291438
- 16. Chatzizacharias NA, Kouraklis GP, Theocharis SE (2008) Disruption of FAK signaling: a side mechanism in cytotoxicity. Toxicology 245: 1–10.NA ChatzizachariasGP KouraklisSE Theocharis2008Disruption of FAK signaling: a side mechanism in cytotoxicity.Toxicology245110
- 17. Hanks SK, Ryzhova L, Shin NY, Brabek J (2003) Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 8: d982–996.SK HanksL. RyzhovaNY ShinJ. Brabek2003Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility.Front Biosci8d982996
- 18. Harvey RD, Lonial S (2007) PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma. Future Oncol 3: 639–647.RD HarveyS. Lonial2007PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma.Future Oncol3639647
- 19. He Z, Koprivica V (2004) The Nogo signaling pathway for regeneration block. Annu Rev Neurosci 27: 341–368.Z. HeV. Koprivica2004The Nogo signaling pathway for regeneration block.Annu Rev Neurosci27341368
- 20. Kotter MR, Li WW, Zhao C, Franklin RJ (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26: 328–332.MR KotterWW LiC. ZhaoRJ Franklin2006Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.J Neurosci26328332
- 21. Halder RC, Jahng A, Maricic I, Kumar V (2007) Mini review: immune response to myelin-derived sulfatide and CNS-demyelination. Neurochem Res 32: 257–262.RC HalderA. JahngI. MaricicV. Kumar2007Mini review: immune response to myelin-derived sulfatide and CNS-demyelination.Neurochem Res32257262
- 22. Kanter JL, Narayana S, Ho PP, Catz I, Warren KG, et al. (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12: 138–143.JL KanterS. NarayanaPP HoI. CatzKG Warren2006Lipid microarrays identify key mediators of autoimmune brain inflammation.Nat Med12138143
- 23. Jeon SB, Yoon HJ, Park SH, Kim IH, Park EJ (2008) Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol 181: 8077–8087.SB JeonHJ YoonSH ParkIH KimEJ Park2008Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells.J Immunol18180778087
- 24. Campbell IL, Stalder AK, Akwa Y, Pagenstecher A, Asensio VC (1998) Transgenic models to study the actions of cytokines in the central nervous system. Neuroimmunomodulation 5: 126–135.IL CampbellAK StalderY. AkwaA. PagenstecherVC Asensio1998Transgenic models to study the actions of cytokines in the central nervous system.Neuroimmunomodulation5126135
- 25. Segal BM, Dwyer BK, Shevach EM (1998) An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 187: 537–546.BM SegalBK DwyerEM Shevach1998An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.J Exp Med187537546
- 26. Eugster HP, Frei K, Kopf M, Lassmann H, Fontana A (1998) IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol 28: 2178–2187.HP EugsterK. FreiM. KopfH. LassmannA. Fontana1998IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.Eur J Immunol2821782187
- 27. Brown MA, Hural J (1997) Functions of IL-4 and control of its expression. Crit Rev Immunol 17: 1–32.MA BrownJ. Hural1997Functions of IL-4 and control of its expression.Crit Rev Immunol17132
- 28. Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1995) Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270: 9558–9563.P. WangP. WuMI SiegelRW EganMM Billah1995Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms.J Biol Chem27095589563
- 29. Qian L, Wei SJ, Zhang D, Hu X, Xu Z, et al. (2008) Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol 181: 660–668.L. QianSJ WeiD. ZhangX. HuZ. Xu2008Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia.J Immunol181660668
- 30. Muller M, Carter SL, Hofer MJ, Manders P, Getts DR, et al. (2007) CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol 179: 2774–2786.M. MullerSL CarterMJ HoferP. MandersDR Getts2007CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.J Immunol17927742786
- 31. Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, et al. (2001) CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617–7624.BT FifeKJ KennedyMC PaniaguaNW LukacsSL Kunkel2001CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.J Immunol16676177624
- 32. Kerschensteiner M, Schwab ME, Lichtman JW, Misgeld T (2005) In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 11: 572–577.M. KerschensteinerME SchwabJW LichtmanT. Misgeld2005In vivo imaging of axonal degeneration and regeneration in the injured spinal cord.Nat Med11572577
- 33. Pan JZ, Ni L, Sodhi A, Aguanno A, Young W, et al. (2002) Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J Neurosci Res 68: 315–322.JZ PanL. NiA. SodhiA. AguannoW. Young2002Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion.J Neurosci Res68315322
- 34. Griffin JW, George R, Lobato C, Tyor WR, Yan LC, et al. (1992) Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination. J Neuroimmunol 40: 153–165.JW GriffinR. GeorgeC. LobatoWR TyorLC Yan1992Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination.J Neuroimmunol40153165
- 35. George R, Griffin JW (1994) Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol 129: 225–236.R. GeorgeJW Griffin1994Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model.Exp Neurol129225236
- 36. Vargas ME, Barres BA (2007) Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci 30: 153–179.ME VargasBA Barres2007Why is Wallerian degeneration in the CNS so slow?Annu Rev Neurosci30153179
- 37. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, et al. (2005) Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 202: 145–156.R. BrambillaV. Bracchi-RicardWH HuB. FrydelA. Bramwell2005Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury.J Exp Med202145156
- 38. Murphy M, Reid K, Hilton DJ, Bartlett PF (1991) Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc Natl Acad Sci U S A 88: 3498–3501.M. MurphyK. ReidDJ HiltonPF Bartlett1991Generation of sensory neurons is stimulated by leukemia inhibitory factor.Proc Natl Acad Sci U S A8834983501
- 39. Hendriks JJ, Slaets H, Carmans S, de Vries HE, Dijkstra CD, et al. (2008) Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol. JJ HendriksH. SlaetsS. CarmansHE de VriesCD Dijkstra2008Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages.J Neuroimmunol
- 40. Koning N, Bo L, Hoek RM, Huitinga I (2007) Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 62: 504–514.N. KoningL. BoRM HoekI. Huitinga2007Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.Ann Neurol62504514
- 41. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, et al. (2000) Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290: 1768–1771.RM HoekSR RuulsCA MurphyGJ WrightR. Goddard2000Down-regulation of the macrophage lineage through interaction with OX2 (CD200).Science29017681771
- 42. Reichert F, Rotshenker S (1996) Deficient activation of microglia during optic nerve degeneration. J Neuroimmunol 70: 153–161.F. ReichertS. Rotshenker1996Deficient activation of microglia during optic nerve degeneration.J Neuroimmunol70153161
- 43. Rotshenker S, Reichert F, Gitik M, Haklai R, Elad-Sfadia G, et al. (2008) Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia 56: 1607–1613.S. RotshenkerF. ReichertM. GitikR. HaklaiG. Elad-Sfadia2008Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia.Glia5616071613